Yuan‐Ju Lee
Papers
1
Total Citations
9
H-Index
1
About
Yuan‐Ju Lee is a prominent urological researcher whose work centers on improving prostate cancer diagnosis and treatment outcomes. His key research areas include biomarker development, surgical pathology prediction, and precision oncology for prostate cancer. Lee’s major contribution lies in evaluating the clinical utility of the prostate health index (PHI) and its derivative, %p2PSA, as predictive tools for aggressive disease. In his highly cited 2020 study, he demonstrated that preoperative %p2PSA and PHI scores could accurately forecast adverse pathological outcomes—such as extraprostatic extension and seminal vesicle invasion—in patients undergoing robot-assisted radical prostatectomy. This work, which has garnered 9 citations, provides clinicians with a non-invasive method to stratify risk and guide treatment decisions, potentially reducing overtreatment of indolent cancers. Lee’s research bridges the gap between serum biomarkers and surgical pathology, offering a practical framework for personalized prostate cancer management. His findings have been instrumental in advancing the use of PHI in preoperative planning, and his ongoing investigations continue to refine risk assessment models for patients with organ-confined disease.
Research Focus
Key Achievements
Top Papers
- 1